Adial Pharmaceuticals Inc
Follow $ADIL
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ADIL by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is ADIL moving today?
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
ADIL overview
Related filings and maps
Congress activity in ADIL
No receipt-qualified Congressional disclosure is present for ADIL in the cached public ledger.
ADIL contract awards, year to date.
Public federal awards linked to this ticker.
ADIL lobbying filings, year to date.
Registered lobbying filings matched to Adial Pharmaceuticals Inc.
RK STRATEGIES, INC.
RK STRATEGIES, INC.
RK STRATEGIES, INC.